May 17, 2010
Cinryze now packed with Mix2Vial needle-less reconstitution systemViroPharma announced that it has begun packaging Cinryze (C1 inhibitor [human]) with West Pharmaceutical's Mix2Vial needle-less reconstitution system. The reconstitution device and accompanying training materials will be widely available in the coming weeks.
Cinryze is a highly purified, pasteurized and nanofiltered plasma-derived C1 esterase inhibitor indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema.
For more information call (610) 458-7300 or visit www.viropharma.com.